 |
|
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
Clin Mol Hepatol. 2023;29(2):242-251. Published online 2023 Mar 20 DOI: https://doi.org/10.3350/cmh.2023.0102
|
|
Citations to this article as recorded by
 Refining MR-guided thermal ablation for HCC within the Milan criteria: a decade of clinical outcomes and predictive modeling at a single institution
Fu-Qun Wei, Pei-Shu Huang, Bing Zhang, Rui Guo, Yan Yuan, Jin Chen, Zheng-Yu Lin
BMC Cancer.2025;[Epub] CrossRef Celecoxib as a potential treatment for hepatocellular carcinoma in populations exposed to high PFAS levels
Boshi Sun, Yuqiao Zhao, Shifeng Yang, Xiaodong Li, Nana Li, Yujie Wang, Qixiang Han, Xuyun Liu, Qiushi Tu, Jie Zheng, Xinyu Zhang
Journal of Hazardous Materials.2025; 489: 137613. CrossRef Reply: Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of hepatocellular carcinoma
Deok Hwa Seo, Pil Soo Sung
Hepatology.2025; 81(4): E123. CrossRef A Chemotherapy Response-Related Gene Signature and DNAJC8 as Key Mediators of Hepatocellular Carcinoma Progression and Drug Resistance
Yan Ye, Yanmei Zeng, Shenggang Huang, Chunping Zhu, Qingshui Wang
Journal of Hepatocellular Carcinoma.2025; Volume 12: 579. CrossRef Decoding Genomic Diversity to Guide Tumor Lesion‐Specific Treatment of Multifocal Hepatocellular Carcinoma
Kenji Amemiya, Yosuke Hirotsu, Yuji Iimuro, Ryosuke Tajiri, Toshio Oyama, Shuntaro Obi, Hitoshi Mochizuki, Masao Omata
Cancer Medicine.2025;[Epub] CrossRef A nomogram based on PNI and preoperative TACE can predict overall survival in patients with larger than 2 cm HCC after hepatectomy
Huizhi Zhang, Chunyu Zhang, Run Hu, Kai Lei, Xingxing Wang, Zuojin Liu
Updates in Surgery.2025;[Epub] CrossRef Hepatocellular Carcinoma: A Comprehensive Review of Pathophysiology, Risk Factors, Diagnosis and Treatment Strategies
Vedika N. Dafe, Pooja R. Hatwar , Ravindra L. Bakal , Harshdeep V. Bindod
Journal of Drug Delivery and Therapeutics.2025; 15(5): 159. CrossRef Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma
Hiroyuki Suzuki, Hideki Iwamoto, Toshimitsu Tanaka, Takahiko Sakaue, Yasuko Imamura, Atsutaka Masuda, Toru Nakamura, Hironori Koga, Yujin Hoshida, Takumi Kawaguchi
Hepatology International.2024; 18(2): 610. CrossRef Case Reports of Pituitary Adrenocortical Insufficiency Following Atezolizumab+Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma
Etsuko Moriyama, Hideki Iwamoto, Takashi Niizeki, Ayako Nagayama, Tomotake Shirono, Shigeo Shimose, Masahito Nakano, Yu Noda, Hiroyuki Suzuki, Miwa Sakai, Ryoko Kuromatu, Hironori Koga, Masatoshi Nomura, Takumi Kawaguchi
Kanzo.2024; 65(1): 37. CrossRef The Immune Inductive Role of Hepatic Arterial Infusion Chemotherapy Prior to Atezolizumab Plus Bevacizumab Combination Therapy in Hepatocellular Carcinoma
Hiroyuki Suzuki, Miwa Sakai, Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Masahito Nakano, Tomotake Shirono, Yu Noda, Etsuko Moriyama, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
Gastro Hep Advances.2024; 3(4): 506. CrossRef Impact of bile leak on the prognosis of patients with hepatocellular carcinoma who have undergone liver resection
Hidetoshi Gon, Shohei Komatsu, Hirotoshi Soyama, Motofumi Tanaka, Kenji Fukushima, Takeshi Urade, Shinichi So, Toshihiko Yoshida, Keisuke Arai, Jun Ishida, Yoshihide Nanno, Daisuke Tsugawa, Hiroaki Yanagimoto, Hirochika Toyama, Masahiro Kido, Takumi Fukum
Langenbeck's Archives of Surgery.2024;[Epub] CrossRef Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
Tianying Ren, Xu Hou, Xin Zhang, Dongliang Chen, Juan Li, Yingnan Zhu, Zhiheng Liu, Dawei Yang
Heliyon.2023; 9(11): e21906. CrossRef Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study
Jonathan Abdelmalak, Simone I. Strasser, Natalie Ngu, Claude Dennis, Marie Sinclair, Avik Majumdar, Kate Collins, Katherine Bateman, Anouk Dev, Joshua H. Abasszade, Zina Valaydon, Daniel Saitta, Kathryn Gazelakis, Susan Byers, Jacinta Holmes, Alexander J.
Cancers.2023; 15(24): 5741. CrossRef
|